Prof. Dr. Mohammad Hossein Mirjalili | Medicinal plants | Best Researcher Award

Prof. Dr. Mohammad Hossein Mirjalili , Shahid beheshti University, Iran

Dr. Mohammad Hossein Mirjalili 🌿 is a professor at Shahid Beheshti University, Iran, specializing in medicinal plants. Born on August 23, 1974, in Yazd, Iran 🇮🇷, he has contributed significantly to plant biotechnology, secondary metabolite production, and phytochemistry. With a Ph.D. from the University of Tehran and international research experience in Spain 🇪🇸, he is recognized for his impactful teaching and research in plant cell culture, genetics, and metabolic engineering 🧬. As head and deputy director at the Medicinal Plants and Drugs Research Institute, Dr. Mirjalili continues to advance innovations in medicinal plant science. 📚👨‍🔬🌱

Professional Profile:

google Scholar

Orcid

Suitability for Best Researcher Award:

Dr. Mohammad Hossein Mirjalili is exceptionally well-suited for the Best Researcher Award, given his pioneering work in medicinal plant biotechnology, metabolic engineering, and plant-derived pharmaceuticals. With decades of sustained academic excellence, research leadership, and international collaboration, his contributions directly impact healthcare, sustainable agriculture, and pharmaceutical sciences.

📘 Education & Experience

🎓 Education

B.Sc. in Horticultural Science, University of Tehran, Karaj, Iran (1994–1998) 🎓
M.Sc. in Horticultural Science (Medicinal Plants), University of Tehran (1999–2000) 🌿
Thesis: Adaptation and essential oil composition of lemongrass landraces
Ph.D. in Physiology and Breeding of Medicinal Plants, University of Tehran (2004–2009) 🧪
Thesis: Withania species and hairy root culture for withanolide production
Ph.D. training in University of Barcelona, Spain 🇪🇸 (2006–2007)

💼 Experience

Master Research Fellow, University of Tehran (1999–2000) 🧑‍🔬
Researcher, Shahid Beheshti University (2001–2004) 🔬
Ph.D. Research Fellow, University of Tehran (2004–2008) 📖
Professor, Shahid Beheshti University (Since 2022) 👨‍🏫
Head, Agriculture Department (2009–2011) 🏛️
Deputy of Education (Since 2016) 📚

🚀 Professional Development

Dr. Mirjalili has demonstrated consistent growth as a scholar and educator in the field of medicinal plant sciences 🌱. His professional trajectory includes academic leadership, extensive teaching at graduate levels, and advanced research in plant biotechnology and metabolic engineering 🧬. He has taught multiple MSc and PhD-level courses including Plant Biotechnology, Plant Stress Physiology, and Tissue Culture since 2009 👨‍🏫. A key contributor to curriculum development and student mentoring, he has also undertaken international scientific training in Spain 🇪🇸. His professional development continues through active research, collaboration, and publication in high-impact scientific journals 📈📄.

🧪 Research Focus

Dr. Mirjalili’s research is centered on the biotechnology of medicinal and aromatic plants 🌿. He investigates genetic and phytochemical diversity, optimization of in vitro culture systems (like hairy roots and cell suspensions), and metabolic engineering for enhanced production of secondary metabolites 🧬💊. His work also explores the transformation of plant systems via Agrobacterium and the study of endophytes for their bioactive compound potential 🧫. The overarching goal is sustainable production of bioactive compounds for pharmaceutical and therapeutic use, making his contributions crucial to plant-based drug development 🌱🔬💡.

🏆 Awards and Honors

🏆 Selected Researcher of Iran – Ministry of Science, Research & Technology (2023)
👨‍🏫 Distinguished Teacher of the Year – Shahid Beheshti University (2015)
🧪 Distinguished Researcher of the Year – Shahid Beheshti University (2013)
🎓 Ph.D. Scholarship Recipient – Ministry of Science, Research & Technology, Iran (2005)

Publication Top Notes:

**1. Steroidal Lactones from Withania somnifera, an Ancient Plant for Novel Medicine**

Authors: M.H. Mirjalili, E. Moyano, M. Bonfill, R.M. Cusido, J. Palazón
Journal: Molecules, Vol. 14(7), pp. 2373–2393
Year: 2009
Cited by: 820
Summary: A comprehensive review of steroidal lactones (withanolides) derived from Withania somnifera, focusing on their medicinal potential, biosynthesis, and future prospects in pharmaceutical development.

**2. Production of the Anticancer Drug Taxol in Taxus baccata Suspension Cultures: A Review**

Authors: S. Malik, R.M. Cusidó, M.H. Mirjalili, E. Moyano, J. Palazón, M. Bonfill
Journal: Process Biochemistry, Vol. 46(1), pp. 23–34
Year: 2011
Cited by: 491
Summary: Reviews advancements in biotechnological methods for producing the anticancer drug taxol from Taxus baccata suspension cultures, including genetic and metabolic engineering strategies.

**3. Essential Oil Composition and Antibacterial Activity of Thymus caramanicus at Different Phenological Stages**

Authors: S.N. Ebrahimi, J. Hadian, M.H. Mirjalili, A. Sonboli, M. Yousefzadi
Journal: Food Chemistry, Vol. 110(4), pp. 927–931
Year: 2008
Cited by: 398
Summary: Investigates how essential oil composition and antibacterial properties of Thymus caramanicus vary across growth stages, with implications for its use in food and pharmaceutical industries.

4. Biotechnological Production of Taxol and Related Taxoids: Current State and Prospects

Authors: O. Expósito, M. Bonfill, E. Moyano, M. Onrubia, M.H. Mirjalili, R.M. Cusidó, et al.
Journal: Anti-Cancer Agents in Medicinal Chemistry
Year: 2009Cited by: 186
Summary: Explores biotechnological innovations for producing taxol and similar taxoids, detailing production platforms such as cell cultures, genetic engineering, and elicitation techniques.

**5. Phytochemical and Morphological Characterization of Satureja khuzistanica Jamzad Populations from Iran**

Authors: J. Hadian, M. Hossein Mirjalili, M. Reza Kanani, A. Salehnia, P. Ganjipoor
Journal: Chemistry & Biodiversity, Vol. 8(5), pp. 902–915
Year: 2011
Cited by: 163
Summary: Provides a detailed chemical and morphological analysis of different Iranian populations of Satureja khuzistanica, a medicinal plant known for high thymol content and therapeutic properties.

Conclusion:

Dr. Mohammad Hossein Mirjalili exemplifies what the Best Researcher Award aims to honor: innovation, impact, and leadership in a critical scientific domain. His decades-long research into the biotechnology of medicinal plants not only advances academic knowledge but also serves global health and sustainability goals. His scientific depth, educational commitment, and national recognition make him a model candidate for this award.

Assoc. Prof. Dr. Kyeong Soo Kim , Gyongsang National University/Dept. of Pharmaceutical Engineering , South Korea

Kyeong Soo Kim is an accomplished researcher and academic based in the Republic of Korea. He currently serves as an Associate Professor in the Department of Pharmaceutical Engineering at Gyeongsang National University. Dr. Kim earned his Ph.D. in Pharmacy from Hanyang University, where he specialized in the development of novel controlled release formulations for fenofibric acid. His research interests span nanotechnology applications for poorly water-soluble drugs, improved pharmaceutical technologies for controlled release dosage forms, inhaled drug delivery systems, and dermal drug delivery systems. Prior to his current position, he held roles as a Postdoctoral Research Associate at the University of Mississippi and as a Principal Scientist at Hanmi Pharm. Co., Ltd., where he gained extensive experience in formulation and process development. Dr. Kim’s expertise includes designing oral and parenteral dosage forms, conducting preformulation studies, and utilizing advanced techniques such as solid dispersion, spray drying, and lipid-based formulations to enhance drug delivery efficacy. He is actively involved in research and has contributed significantly to the field through his publications and professional engagements.

Professional Profile:

Scopus

Education:

Kyeong Soo Kim is a distinguished academic and researcher in the field of pharmacy, currently holding the position of Associate Professor at Gyeongsang National University in the Republic of Korea. He completed his Ph.D. in Pharmacy at Hanyang University from March 2011 to August 2015, under the guidance of Professor Han-Gon Choi, Ph.D. His doctoral research focused on the development of innovative controlled release formulations for fenofibric acid. Prior to his doctoral studies, he earned a Master of Science in Pharmacy at Chungbuk National University from March 2002 to August 2004, where his research investigated the depigmenting effects and mechanisms of piperlonguminine derived from Piper longum. Kyeong Soo Kim began his academic journey with a Bachelor of Science in Pharmacy, also from Chungbuk National University, completed from March 1998 to February 2002. His educational background underscores his expertise in pharmaceutical sciences, particularly in drug delivery systems and formulation development.

Work Experience:

Kyeong Soo Kim is currently an Associate Professor in the Department of Pharmaceutical Engineering at Gyeongsang National University in the Republic of Korea, a position he has held since September 2017. Prior to joining Gyeongsang National University, Dr. Kim served as a Postdoctoral Research Associate at the Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, USA, from September 2016 to August 2017. Before his time in the United States, he worked as a Postdoctoral Research Fellow at the Laboratory of Industrial & Physical Pharmacy at Hanyang University, Republic of Korea, from September 2015 to August 2016. Dr. Kim’s extensive professional experience also includes a significant tenure as a Principal Scientist and Team Manager at the Pharmaceutical R&D Center of Hanmi Pharm. Co., Ltd., Republic of Korea, where he contributed from August 2004 to November 2014. His career path highlights his expertise in pharmaceutical engineering, drug delivery systems, and research leadership in both academic and industrial settings.

Publication Top Notes:

“Improved bioavailability and high photostability of methotrexate by spray-dried surface-attached solid dispersion with an aqueous medium” by Giri, B.R., Kim, J.S., Park, J.H., … Choi, H.G., Kim, D.W.
- Journal: Pharmaceutics, 2021, 13(1), pp. 1–14, 111
- Citations: 36
“Nitration of protein phosphatase 2A increases via Epac1/PLCε/CaMKII/HDAC5/iNOS cascade in human endometrial stromal cell decidualization” by Lee, S.Y., Lee, Y.Y., Choi, J.-S., … Park, S.-Y., Han, J.-S.
- Journal: FASEB Journal, 2020, 34(11), pp. 14407–14423
- Citations: 2
“Development of Novel d-Cycloserine Tablet with Improvement of Drug Stability and Dissolution-Equivalence to the d-Cycloserine-Loaded Commercial Hard Capsule” by Kim, J.S., Choi, Y.J., Woo, M.R., … Jin, S.G., Choi, H.-G.
- Journal: Bulletin of the Korean Chemical Society, 2020, 41(6), pp. 603–608
- Citations: 3
“Enhanced Chemical Stability of D-Cycloserine via Tablet Form Containing Magnesium Oxide as an Alkali Stabilizer” by Kim, J.S., Lee, S.M., Kim, D.S., … Jin, S.G., Choi, H.-G.
- Journal: Bulletin of the Korean Chemical Society, 2020, 41(1), pp. 10–14
- Citations: 1
“Self-microemulsifying drug delivery system (SMEDDS) for improved oral delivery and photostability of methotrexate” by Kim, D.S., Cho, J.H., Park, J.H., … Choi, H.-G., Kim, D.W.
- Journal: International Journal of Nanomedicine, 2019, 14, pp. 4949–4960
- Citations: 61